Reaction profile

The FDA adverse-event record for brain tumour

48 FDA reports name brain tumour, a lower-volume reaction in the CVM extract (VeDDRA 3105). Plate stamps and neighbourhood peers follow.

#1756 of 2,481
by report volume (all reactions)
48
reports citing this reaction
72.9%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Brain tumour has 48 reports now versus 42 in that prior snapshot: 6 more (14.3%).

Report change
+6
Death-coded reports
+5
Death-coded share
+1.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Brain tumour changes

FDA AER · VeDDRA plate

Code 3105 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 48 reports
  • DEATH-HOT 72.9%
  • MID-PACK #1756/2481
  • PHOTO-FINISH Abnormal echocardiogr…
  • SPECIES-DOG Dog · 41
  • DRUG-LEAD Bedinvetmab · 20
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal echocardiogram (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Brain tumour

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal echocardiogr… · near48Application site absc… · near48Brain damage NOS · near48Brain tumour · this reaction48Infarction · near48Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Brain tumour

Brain tumour: high death-coded share in the FDA AER plate

Signature read: Brain tumour's 72.9% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 48 named reports in the openFDA extract. Death-coded share is upper-third: 35 of 48 reports (72.9% of named reports). Nearest volume peer: Abnormal echocardiogram (±0 reports). Lead species Dog (41). Lead co-reported drug Bedinvetmab (20).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 41
Cat 7

Breeds Most Affected

Dog (unknown) 4
Crossbred Canine/dog 4
Bulldog - French 3
Domestic Longhair 3
Retriever - Golden 3
Retriever - Labrador 3
Shih Tzu 2
Boxer (German Boxer) 2
Siberian Husky 2
Ragdoll 2

Associated Drugs

Bedinvetmab 20
Maropitant Citrate 7
Carprofen 7
Prednisone 6
Oclacitinib Maleate 5
Frunevetmab 4
Pyrantel Pamoate;Sarolaner 4
Gabapentin 4
Robenacoxib 4
Fluid Therapy 3
Fluralaner 13.64% 12-Week Chew 3
Phenobarbital 2
Prednisolone 2
Milbemycin Oxime + Praziquantel 2
Milbemycin Oxime 2
Genta/Betamet/Clotrim Ear Oint 2
Cefovecin Sodium 2
Trilostane 2
Milbemycin Oxime + Spinosad 2
Grapiprant 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Brain tumour (#1756 of 2,481 by report volume); death-coded 72.9%. PlainBreed reaction plate · death-coded share stamp 72.9% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →